A Systematic Review of Cost-Effectiveness Models in Type 1 Diabetes Mellitus

Henriksson M, Jindal R, Sternhufvud C, Bergenheim K, Sörstadius E & Willis M

Diabetes mellitus is a group of chronic metabolic diseases that result from dysfunction in the production of or response to insulin. Type 1 diabetes mellitus (T1DM) typically manifests in childhood and is characterised by an absolute insulin deficiency due to T cell-mediated autoimmune destruction of pancreatic β cells.

This review identified published economic models in T1DM and provided an overview of the characteristics and capabilities of available models, thus enabling a discussion of best-practice modelling approaches in T1DM.

Pharmacoeconomics, 2016 Jun; 34(6): 569-85
DOI:: 10.1007/s40273-015-0374-8